doi: 10.1128/AAC.30.1.189.
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon
- PMID: 3019235
- PMCID: PMC176465
- DOI: 10.1128/AAC.30.1.189
Item in Clipboard
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon
Antimicrob Agents Chemother.
1986 Jul.
Abstract
Phosphonoformate and recombinant alpha-A interferon synergistically inhibited the replication of human T-cell lymphotropic virus type III in cultured peripheral blood lymphocytes. T-cell proliferative capability was maintained by this combination, and toxicity was minimal.
Similar articles
-
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.Lancet. 1985 Jun 29;1(8444):1480-2. doi: 10.1016/s0140-6736(85)92255-x. Lancet. 1985. PMID: 2409414
-
Inhibition of HTLV-III/LAV replication by foscarnet.Biochem Pharmacol. 1985 Nov 15;34(22):4075-9. doi: 10.1016/0006-2952(85)90392-2. Biochem Pharmacol. 1985. PMID: 2415134 No abstract available.
-
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate.Arch Virol. 1980;66(3):261-4. doi: 10.1007/BF01314739. Arch Virol. 1980. PMID: 6449917
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
-
Prospects of therapy for infections with human T-lymphotropic virus type III.Ann Intern Med. 1985 Nov;103(5):750-5. doi: 10.7326/0003-4819-103-5-750. Ann Intern Med. 1985. PMID: 2413793 Review.
Cited by
-
Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.Antimicrob Agents Chemother. 1988 Feb;32(2):265-7. doi: 10.1128/AAC.32.2.265. Antimicrob Agents Chemother. 1988. PMID: 2834997 Free PMC article.
-
Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.Klin Wochenschr. 1991 May 24;69(8):360-7. doi: 10.1007/BF02115785. Klin Wochenschr. 1991. PMID: 1909399 Clinical Trial.
-
Antiviral therapy in human immunodeficiency virus infections. Current status (Part II).Drugs. 1993 May;45(5):637-53. doi: 10.2165/00003495-199345050-00002. Drugs. 1993. PMID: 7686460 Review.
-
Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.Proc Natl Acad Sci U S A. 1987 Nov;84(22):8120-4. doi: 10.1073/pnas.84.22.8120. Proc Natl Acad Sci U S A. 1987. PMID: 2825177 Free PMC article.
-
Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnet.Antimicrob Agents Chemother. 1989 May;33(5):778-80. doi: 10.1128/AAC.33.5.778. Antimicrob Agents Chemother. 1989. PMID: 2526616 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
